Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites?

BACKGROUND: There is a large lack of evidence for optimal treatment in oligometastatic head and neck cancer and it is especially unclear which patients benefit from radical local treatment of all tumour sites. METHODS: 40 patients with newly diagnosed oligometastatic head and neck cancer received ra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Radiat Oncol
Autors principals: Weissmann, Thomas, Höfler, Daniel, Hecht, Markus, Semrau, Sabine, Haderlein, Marlen, Filimonova, Irina, Frey, Benjamin, Bert, Christoph, Lettmaier, Sebastian, Mantsopoulos, Konstantinos, Iro, Heinrich, Fietkau, Rainer, Putz, Florian
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011153/
https://ncbi.nlm.nih.gov/pubmed/33789725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-021-01790-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars